By the time her cancer was caught, six months after her symptoms began and two days after her 46th birthday, Louise Greenbank ...

Paul Silvester, from Sheffield, was diagnosed with Myeloma in July 2023 after his cancer caused broken vertebrae in his spine ...

The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...

Terminal patients could get years more with their loved ones as the NHS offers Blenrep, which can put some blood cancer patients in remission ...

A Sheffield man has become one of the first patients in the world to benefit from a pioneering therapy that could halt the ...

IRAKLIA, the first phase 3 multiple myeloma study to use an on-body injector, finds the same efficacy and pharmacokinetics in ...

Two posters presented at the 2025 European Hematology Association Congress support combination therapy with daratumumab, ...

Patients with relapsed/refractory (R/R) multiple myeloma and lower socioeconomic status reported significantly worse quality of life and a higher burden of symptoms, according to Francesco Sparano, ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

A retrospective study presented at the recent American Society of Clinical Oncology (ASCO) meeting suggested that patients ...

GSK's drive to resurrect its multiple myeloma therapy Blenrep has continued with new data from the DREAMM-7 trial showing an increase in overall survival (OS) with the drug had reached statistical ...